Evidence map›Paper›PMID 42260227›Full record

ArticleInfectious diseases and therapy2026

Publisher Correction: Modeling the Public Health Impact of Introducing 4CMenB Vaccination for Infants in the Brazilian National Immunization Program.

Thatiana Pinto, Zeki Kocaata, Ana Medina, Igor Sampietri, Graziela Bernardino, Justyna Zawieja, Yaneth Gil-Rojas, Anna Tytuła, Maria Gabriela Graña, Elise Kuylen

Abstract readPublished Erratum
In one paragraph

Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Thatiana PintoGSK, Wavre, Belgium. thatiana.x.pinto@gsk.com.ORCID http://orcid.org/0000-0002-0957-3118
Zeki KocaataGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0002-5231-3389
Ana MedinaGSK, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-8216-2350
Igor SampietriGSK, Wavre, Belgium.ORCID http://orcid.org/0009-0000-1557-7062
Graziela BernardinoGSK, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-8117-4648
Justyna ZawiejaPutnam, Krakow, Poland.ORCID http://orcid.org/0009-0006-9759-1960
Yaneth Gil-RojasPutnam, London, UK.ORCID http://orcid.org/0000-0002-9908-4878
Anna TytułaPutnam, Krakow, Poland.ORCID http://orcid.org/0009-0004-8827-1469
Maria Gabriela GrañaGSK, Santiago, Chile.ORCID http://orcid.org/0000-0001-9577-4428
Elise KuylenGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0002-3528-5507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42260227
PMCPMC13350770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.